Sandra Yvette Campos

CIK: 0001865087

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PETS

PETMED EXPRESS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

PETS
PETMED EXPRESS INC
Apr 30, 2025
Sale(S)
Direct
58.9K shares at avg. $3.31$195K
PETS
PETMED EXPRESS INC
Apr 30, 2025
Sale(S)
Direct
1.6K shares at avg. $3.33$5K
PETS
PETMED EXPRESS INC
Jan 15, 2025
Award(A)
Direct
146.8K shares-

		Type	Shares	Price		Ownership
Apr 30, 2025	PETS PETMED EXPRESS INC	Sale(S)	58,898	$3.31	$194,876	Direct
Apr 30, 2025	PETS PETMED EXPRESS INC	Sale(S)	1,565	$3.33	$5,214	Direct
Jan 15, 2025	PETS PETMED EXPRESS INC	Award(A)	146,772	-	$0	Direct

1-3 of 3 transactions

About Campos Sandra Yvette

Campos Sandra Yvette (SEC CIK 0001865087) files insider reports with the SEC as CEO & President of PETMED EXPRESS INC (PETS).

Signal8 holds 2 ownership filings by Campos Sandra Yvette, all Form 4s, filed between Jan 17, 2025 and May 2, 2025. Those filings report 3 transactions, from Jan 15, 2025 to Apr 30, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Campos Sandra Yvette's filings is in DELRAY BEACH, FL.

Recent filings by Campos Sandra Yvette

Apr 30, 2025: Open-market sales of PETS shares (2 lines, Form 4, code S).
Jan 15, 2025: Grant or award of PETS shares (Form 4, code A).

Other insiders filing for PETMED EXPRESS INC (PETS)

Willard Jeffrey Allen, CEO and President
Elkeles Tamar, Director
Campbell Leslie C.G., Interim CEO and President
LaCamp James, Director
Batushansky Peter, Director
Mennen Justin L., Director

How to read Form 4 transaction codes